The NEJM Knowledge+ Internal Medicine Review app, a flashcard app from the American College of Physicians, and 3 more apps that can help busy physicians ace any board exam.
First-Ever CGM Cleared for 365-Day Use
The only CGM system cleared for 1 year of use in type 1 and 2 diabetes is expected to be available in the fourth quarter of this year, the manufacturers said.
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Pfizer Has Launched PfizerForAll, an Online Multipronged Direct-to-Consumer Service
PfizerForAll offers telehealth and prescription services, vaccination scheduling and savings programs, and is partnering with recognized companies such as InstaCart.
Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns
Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.
SECURE-T2D: Automated Insulin Delivery System Reduced A1c in Adults with Type 2 Diabetes
ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.
CGM Data May Enhance Prediction of Risk for Type 1 Diabetes in Those with Early Stage Disease
ADA 2024. The risk of progression to stage 3 type 1 diabetes may be better predicted using a combination of patient and CGM data, a new study suggests.